Wang Zhen-Zhen, Zeng Rui, Wu Zi-Wei, Wang Chen, Jiang Hai-Qin, Wang Hong-Sheng
Hospital of Skin Diseases and Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, St. 12 Jiangwangmiao, Nanjing, Jiangsu, China.
Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Curr Allergy Asthma Rep. 2023 Nov;23(11):635-645. doi: 10.1007/s11882-023-01109-7. Epub 2023 Oct 7.
As a sulfone antibacterial agent, dapsone has been widely used to treat leprosy. Moreover, dapsone is also used in many immune diseases such as herpetic dermatitis because of its anti-inflammatory and immunomodulatory effects. However, dapsone can cause several adverse effects, the most serious being dapsone hypersensitivity syndrome. Dapsone hypersensitivity syndrome is characterized by a triad of eruptions, fever, and organ involvement, which limits the application of dapsone to some extent.
In this article, we review current research about the interaction model between HLA-B*13:01, dapsone, and specific TCR in dapsone-induced drug hypersensitivity. In addition to the proposed mechanisms, we also discussed clinical features, treatment progress, prevalence, and prevention of dapsone hypersensitivity syndrome. These studies reveal the pathogenesis, clinical features, and prevalence from the perspectives of genetic susceptibility and innate and adaptive immunity in dapsone hypersensitivity syndrome, thereby guiding clinicians on how to diagnose, prevent, and treat dapsone hypersensitivity syndrome.
作为一种砜类抗菌剂,氨苯砜已被广泛用于治疗麻风病。此外,由于其抗炎和免疫调节作用,氨苯砜还被用于治疗许多免疫性疾病,如疱疹性皮炎。然而,氨苯砜可引起多种不良反应,最严重的是氨苯砜超敏综合征。氨苯砜超敏综合征的特征是皮疹、发热和器官受累三联征,这在一定程度上限制了氨苯砜的应用。
在本文中,我们综述了目前关于氨苯砜诱导的药物超敏反应中HLA - B*13:01、氨苯砜和特异性TCR之间相互作用模型的研究。除了所提出的机制外,我们还讨论了氨苯砜超敏综合征的临床特征、治疗进展、患病率和预防措施。这些研究从遗传易感性以及先天性和适应性免疫的角度揭示了氨苯砜超敏综合征的发病机制、临床特征和患病率,从而指导临床医生如何诊断、预防和治疗氨苯砜超敏综合征。